Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael BöhmKlinik für Innere Medizin III, Universität des Saarlandes, Homburg, Germany. Electronic address: [email protected]Helmut SchumacherKoon TeoPopulation Health Research Institute, McMaster University, Hamilton, ON, CanadaEva LonnPopulation Health Research Institute, McMaster University, Hamilton, ON, CanadaFelix MahfoudKlinik für Innere Medizin III, Universität des Saarlandes, Homburg, GermanyJohannes F.E. MannKfH Kidney Center, Munich and Department of Nephrology and Hypertension, University Hospital, Friedrich-Alexander University, Erlangen-Nuremberg, GermanyGiuseppe ManciaUniversity of Milano-Bicocca, Istituto Clinico Universitario Policlinico di Monza, Milan, ItalyJosep RedónHypertension Unit, Hospital CIínico Universitario, University of Valencia, Valencia, SpainRoland E. SchmiederDepartment of Nephrology and Hypertension, University Hospital, Friedrich-Alexander University, Erlangen-Nuremberg, GermanyKaren SliwaHatter Institute for Cardiovascular Research in Africa and IIDMM, Faculty of Health Sciences, University of Cape Town, Cape Town, South AfricaMichael A. WeberState University of New York, Downstate College of Medicine, Brooklyn, NY, USABryan WilliamsUniversity College London (UCL) Institute of Cardiovascular Science and National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, UKSalim YusufPopulation Health Research Institute, McMaster University, Hamilton, ON, Canada
2017en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0